©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Oct 26, 2024; 16(10): 854-859
Published online Oct 26, 2024. doi: 10.4252/wjsc.v16.i10.854
Published online Oct 26, 2024. doi: 10.4252/wjsc.v16.i10.854
Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?
Xiao-Qian Shan, Lan Zhao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibus
Author contributions: Shan XQ contributed to the conceptualization, writing-review and editing; Zhao L participated in the supervision of this manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Lan Zhao, MD, PhD, Professor, Researcher, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, No. 88 Changling Road, Xiqing District, Tianjin 300381, China. lanzhao69@163.com
Received: July 21, 2024
Revised: September 6, 2024
Accepted: October 8, 2024
Published online: October 26, 2024
Processing time: 95 Days and 10.6 Hours
Revised: September 6, 2024
Accepted: October 8, 2024
Published online: October 26, 2024
Processing time: 95 Days and 10.6 Hours
Core Tip
Core Tip: Metabolic dysfunction-associated fatty liver disease is a serious health challenge, and new therapies are urgently needed. Jiang et al proposed mesenchymal stem cells as a promising therapeutic approach for metabolic dysfunction-associated fatty liver disease, emphasizing the targeting of key molecular pathways such as glycolipid metabolism, inflammation, oxidative stress, endoplasmic reticulum stress, and fibrosis. This paper concurs this opinion and further discusses some strategies enhance functionality mesenchymal stem cells.